Prediction of seizure recurrence using electroencephalogram analysis with multiscale deep neural networks before withdrawal of antiepileptic drugs

Pediatr Neonatol. 2022 May;63(3):283-290. doi: 10.1016/j.pedneo.2021.12.011. Epub 2022 Mar 15.

Abstract

Background: The decision to continue or discontinue antiepileptic drug (AED) treatment in patients who are seizure free for a prolonged time is critical. Studies have used certain risk factors or electroencephalogram (EEG) findings to predict seizure recurrence after the withdrawal of AEDs. However, applicable biomarkers to guide the withdrawal of AEDs are lacking.

Methods: In this study, we used EEG analysis based on multiscale deep neural networks (MSDNN) to establish a method for predicting seizure recurrence after the withdrawal of AEDs. A total of 60 patients with epilepsy were divided into two groups (30 in the recurrence group and 30 in the non-recurrence group). All patients were seizure free for at least 2 years. Before AED withdrawal, an EEG was performed for each patient, which showed no epileptiform discharges. These EEG recordings were classified using MSDNN.

Results: We found that the performance indices of classification between recurrence and non-recurrence groups had a mean sensitivity, mean specificity, mean accuracy, and mean area under the receiver operating characteristic curve of 74.23%, 75.83%, 74.66%, and 82.66%, respectively.

Conclusion: Our proposed method is a promising tool to help physicians to predict seizure recurrence after AED withdrawal among seizure-free patients.

Keywords: antiepileptic drug; multiscale deep neural networks; withdrawal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticonvulsants* / therapeutic use
  • Electroencephalography
  • Humans
  • Neural Networks, Computer
  • Recurrence
  • Seizures* / drug therapy

Substances

  • Anticonvulsants